Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MDR1 reversal: criteria for clinical trials designed to overcome the multidrug resistance phenotype.

Leukemia - 1 Jul 1996

Hegewisch-Becker S

Abstract excerpt

Multidrug resistance (MDR) is a widely studied mechanism of cellular resistance to structurally unrelated cytotoxic agents. The MDR phenotype is related to the overexpression of the MDR1 gene product, P-glycoprotein (P-gp), a transmembrane drug efflux pump. The capacity to compete with the cytotoxic drug for the active outward transport process, thus inhibiting the activity of the P-gp pump, has been demonstrated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily B, Member 1
Share to Drug Resistance, Multiple

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Gene Expression Regulation, Neoplastic

Share to Neoplasms

Share to Phenotype

Share to Time Factors

Share to Up-Regulation

Source

Identifiers

PMID: 8656698

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MDR1 reversal: criteria for clinical trials designed to overcome the multidrug resistance phenotype.PMID 8656698Read ↗

An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer ChemotherapySemantic proximity Read ↗

The MDR phenotype in hematologic malignancies: prognostic relevance and future perspectives.Semantic proximity Read ↗

Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR).Semantic proximity Read ↗

Small‐molecule inhibitors of multidrug resistance‐associated protein 1 and related processes: A historic approach and recent advancesSemantic proximity Read ↗

Inhibitors of Multidrug Resistance to Antitumor Agents (MDR)Semantic proximity Read ↗

Multidrug resistance in oncology: diagnostic and therapeutic approachesSemantic proximity Read ↗

New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in CancerSemantic proximity Read ↗

Clinical trials of agents that reverse multidrug resistance. A literature review.Semantic proximity Read ↗

Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer TreatmentSemantic proximity Read ↗

Strategies to Overcome or Circumvent P-Glycoprotein Mediated Multidrug ResistanceSemantic proximity Read ↗

Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance.Semantic proximity Read ↗

Multidrug Resistance in Cancer: Its Mechanism and its ModulationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.